| J06BA02 |
Immunoglobulins, normal human, for intravascular adm. |
OCTAGAM 10% |
Solution for infusion |
100 mg/ml - 20 ml |
mg |
1 |
Octapharma (IP) SPRL, Белгия |
1 |
mg |
193.39 |
0.089154 |
178.31 |
100% |
|
Съгласно РУ |
№ 86/17.06.2010; КЦРР-1354/05.09.2012 г; НСР-17141/01.11.2018; НСР-17624/20.12.2018 |
02.02.2019 |
08.09.2012 |
Активен |
1588 |
| J06BA02 |
Immunoglobulins, normal human, for intravascular adm. |
OCTAGAM 10% |
Solution for infusion |
100 mg/ml - 50 ml |
mg |
1 |
Octapharma (IP) SPRL, Белгия |
1 |
mg |
459.58 |
0.089154 |
445.77 |
100% |
|
Съгласно РУ |
№ 86/17.06.2010; КЦРР-1354/05.09.2012 г; НСР-6208/21.05.2015. и КП-363/26.08.2015.; НСР-9357/19.05.2016 и КП-108/13.09.2016; КП-76/10.10.2017 и НСР-13285/20.07.2017; НСР-16434/09.08.2018; НСР-17622/20.12.2018 |
02.02.2019 |
08.09.2012 |
Активен |
1589 |
| J06BA02 |
Immunoglobulins, normal human, for intravascular adm. |
OCTAGAM 10% |
Solution for infusion |
100 mg/ml - 100 ml |
mg |
1 |
Octapharma (IP) Ltd., Обединено Кралство |
1 |
mg |
923.93 |
0.09148 |
914.8 |
100% |
|
Съгласно РУ |
№ 86/17.06.2010; КЦРР-1354/05.09.2012 г; НСР-6209/21.05.2015. и КП-362/26.08.2015.; НСР-9358/19.05.2016 и КП-109/13.09.2016; НСР-13435/04.08.2017 |
02.09.2017 |
08.09.2012 |
Заличен |
1590 |
| J06BA02 |
Immunoglobulins, normal human, for intravascular adm. |
OCTAGAM 10% |
Solution for infusion |
100 mg/ml - 200 ml |
mg |
1 |
Octapharma (IP) Ltd., Обединено Кралство |
1 |
mg |
1876.97 |
0.09148 |
1829.6 |
100% |
|
Съгласно РУ |
№ 86/17.06.2010; КЦРР-1354/05.09.2012 г; НСР-6210/21.05.2015. и КП-361/26.08.2015.; НСР-9359/19.05.2016 и КП-107/13.09.2016; НСР-13432/04.08.2017 |
02.09.2017 |
08.09.2012 |
Заличен |
1591 |
| J06BA02 |
Immunoglobulins, normal human |
Privigen |
Solution for infusion |
100 mg/ml - 50 ml |
|
1 |
CSL Behring GmbH, Германия |
1 |
mg |
458.26 |
0.089154 |
445.77 |
100% |
|
Съгласно РУ |
№ 190/ 22.08.2011; НСР-212/20.06.2013.; НСР-7188/09.10.2015.; НСР-11147/08.12.2016; НСР-15139/02.03.2018; НСР-18826/30.05.2019 |
02.07.2019 |
08.09.2012 |
Активен |
2007 |
| J06BA02 |
Immunoglobulins, normal human |
Privigen |
Solution for infusion |
100 mg/ml - 25 ml |
|
1 |
CSL Behring GmbH, Германия |
1 |
mg |
232.84 |
0.089154 |
222.89 |
100% |
|
Съгласно РУ |
№ 190/ 22.08.2011; НСР-154/18.06.2013.; НСР-7187/09.10.2015.; НСР-11146/08.12.2016; НСР-15138/02.03.2018; НСР-18825/30.05.2019 |
02.07.2019 |
08.09.2012 |
Активен |
2006 |
| J06BA02 |
Immunoglobulins, normal human |
Privigen |
Solution for infusion |
100 mg/ml - 100 ml |
|
1 |
CSL Behring GmbH, Германия |
1 |
mg |
891.54 |
0.089154 |
891.54 |
100% |
|
Съгласно РУ |
№ 190/ 22.08.2011; НСР-155/18.06.2013.; НСР-7189/09.10.2015.; НСР-11148/08.12.2016 г.; НСР-15140/02.03.2018 |
02.04.2018 |
08.09.2012 |
Активен |
2008 |
| J06BA02 |
Immunoglobulins, normal human, for intravascular adm. |
J06BA02 Immunoglobulins, normal human, for intravascular adm. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| J06BA02 |
Immunoglobulins, normal human, for intravascular adm. |
IMMUNOVENIN-INTACT 5% IgG |
Solution for infusion |
50 mg/ml - 5 ml |
mg |
10 |
БУЛ БИО-НЦЗПБ ЕООД, България |
1 |
mg |
128.54 |
0.05142 |
128.54 |
100% |
|
Съгласно РУ |
НСР-9817/21.07.2016; Протокол №190/21.09.2016 |
02.10.2016 |
08.09.2012 |
Активен |
1318 |
| J06BA02 |
Immunoglobulins, normal human, for intravascular adm. |
Intratect |
Solution for infusion |
50g/l - 200 ml |
mg |
1 |
Biotest Pharma GmbH, Германия |
1 |
mg |
929.98 |
0.05142 |
514.2 |
100% |
|
Съгласно РУ |
КЦРР-2680/20.03.2013 г.; Протокол № 190/21.09.2016; НСР-13515/18.08.2017; НСР-18597/25.04.2019 |
02.06.2019 |
|
Заличен |
1840 |
| J06BA02 |
Immunoglobulins, normal human, for intravascular adm. |
Intratect |
Solution for infusion |
50g/l - 20 ml |
mg |
1 |
Biotest Pharma GmbH, Германия |
1 |
mg |
95.46 |
0.05142 |
51.42 |
100% |
|
Съгласно РУ |
КЦРР-2678/20.03.2013 г.; Протокол № 190/21.09.2016; НСР-13518/18.08.2017; НСР-18588/25.04.2019 |
02.06.2019 |
|
Заличен |
1838 |
| J06BA02 |
Immunoglobulins, normal human, for intravascular adm. |
Intratect |
Solution for infusion |
50g/l - 100 ml |
mg |
1 |
Biotest Pharma GmbH, Германия |
1 |
mg |
471 |
0.05142 |
257.1 |
100% |
|
Съгласно РУ |
КЦРР-2679/20.03.2013 г.; Протокол № 190/21.09.2016; НСР-13516/18.08.2017; НСР-16088/05.07.2018 |
02.08.2018 |
|
Заличен |
1839 |
| J06BA02 |
Immunoglobulins, normal human, for intravascular adm. |
Intratect |
Solution for infusion |
50g/l - 50 ml |
mg |
1 |
Biotest Pharma GmbH, Германия |
1 |
mg |
238.67 |
0.05142 |
128.55 |
100% |
|
Съгласно РУ |
КЦРР-2677/20.03.2013 г.; Протокол № 190/21.09.2016; НСР-13517/18.08.2017; НСР-16087/05.07.2018 |
02.08.2018 |
|
Заличен |
1837 |
| J06BB01 |
Anti-D (rh) immunoglobulin |
J06BB01 Anti-D (rh) immunoglobulin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| J06BB01 |
Anti-D (rh) immunoglobulin |
HYPERRHO S/D FULL DOSE |
Solution for injection |
300 |
mcg |
1 |
Химимпорт Фарма АД, България |
1 |
mcg |
157.94 |
0.52647 |
157.94 |
100% |
|
Съгласно РУ |
НСР-4557/03.09.2014; НСР-9436/01.06.2016 |
02.07.2016 |
08.09.2012 |
Заличен |
3163 |
| J06BB04 |
Human hepatitis B immunoglobulin |
J06BB04 Human hepatitis B immunoglobulin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| J06BB04 |
Hepatitis B immunoglobulin |
Hepatect CP |
Solution for infusion |
50 IU/ml - 10 ml |
IU |
1 флакон |
Biotest Pharma GmbH, Германия |
1 |
IU |
375.78 |
0.73357 |
366.79 |
100% |
|
Съгласно РУ |
№ 145/ 28.01.2011; КЦРР-428/19.04.2012 г.; НСР-19387/02.08.2019 |
02.09.2019 |
08.09.2012 |
Активен |
1197 |
| J06BB04 |
Hepatitis B immunoglobulin |
Hepatect CP |
Solution for infusion |
50 IU/ml - 40 ml |
IU |
1 флакон |
Biotest Pharma GmbH, Германия |
1 |
IU |
1467.13 |
0.73357 |
1467.13 |
100% |
|
Съгласно РУ |
№ 145/ 28.01.2011; КЦРР-428/19.04.2012 г.; НСР-19391/02.08.2019 |
02.09.2019 |
08.09.2012 |
Активен |
1198 |
| J06BB04 |
Hepatitis B immunoglobulin |
Hepatect CP |
Solution for infusion |
50 IU/ml - 2 ml |
IU |
1 флакон |
Biotest Pharma GmbH, Германия |
1 |
IU |
83.23 |
0.80633 |
80.63 |
100% |
|
Съгласно РУ |
№ 145/ 28.01.2011; КЦРР-433/19.04.2012 г.; НСР-18251/22.03.2019 |
02.05.2019 |
08.09.2012 |
Заличен |
1172 |
| J07AG01 |
Haemophilus tipe b conjugate vaccine |
J07AG01 Haemophilus tipe b conjugate vaccine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| J07AG01 |
Hemophilus Influenzae B, Purified Antigen Conjugated |
Hiberix |
Powder and solvent for solution for injection |
Haemophilus influenzae type B polysaccharide – 10 μg, conjugated to 30 μg tetanus toxoid |
mg |
1 |
ГлаксоСмитКлайн ЕООД, България |
|
- |
23.36 |
|
23.36 |
100% |
|
Съгласно РУ |
КЦРР-888/28.06.2012 г.; КЦРР-2939/20.03.2013 |
26.04.2013 |
08.09.2012 |
Заличен |
1281 |
| J07AJ52 |
Diphtheria, Tetanus and Pertussis (acellular, component) vaccine |
J07AJ52 Diphtheria, Tetanus and Pertussis (acellular, component) vaccine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| J07AJ52 |
pertussis, purified antigen, combinations with toxoids |
Adacel |
Suspension for injection |
0.5 |
ml |
prefilled syringe with 2 separate needles x 10 |
Sanofi Pasteur S.A., Франция |
1 |
dose |
950.75 |
95.075 |
950.75 |
100% |
|
Съгласно РУ |
НСР-19502/14.08.2019 |
02.09.2019 |
|
Активен |
15515 |
| J07AJ52 |
pertussis, purified antigen, combinations with toxoids |
Adacel |
Suspension for injection |
0.5 |
ml |
prefilled syringe with 1 separate needle x 10 |
Sanofi Pasteur S.A., Франция |
1 |
dose |
950.75 |
95.075 |
950.75 |
100% |
|
Съгласно РУ |
НСР-19502/14.08.2019 |
02.09.2019 |
|
Активен |
15505 |
| J07AJ52 |
pertussis, purified antigen, combinations with toxoids |
Infanrix |
Suspension for injection |
Diphtheria toxoid ≥ 30 IU Filamentous haemagglutinin 25 μg Pertussis toxoid 25 μg Tetanus toxoid ≥ 40 IU Pertactin 8 μg |
mg |
1 |
GlaxoSmithKline Biologicals S.A., Белгия |
|
- |
22.91 |
|
22.91 |
100% |
|
Съгласно РУ |
КЦРР-2476/27.02.2013. |
21.03.2013 |
08.09.2012 |
Заличен |
130 |